Global Healthcare Leader Selects Kneat Kneat has signed a Master Services Agreement with a global provider of critical care products with over 50,000 employees.

Kneat Announces Record Revenue for Fourth Quarter and Full Year 2023 Kneat's Q4 and 2023 financial results show Annual Recurring Revenue up 55% year over year, to $37.4 million, and record gross margin of 72% in Q4.

Kneat Announces Closing of $20 Million Bought Deal Including Full Exercise of Over-Allotment Option Kneat announced the closing of its bought deal: it issued 6,153,880 common shares at $3.25 per share for gross proceeds of $20,000,110.

Kneat to Announce 2023 Fourth-Quarter and Fiscal Year Financial Results February 21, 2024 Kneat will announce its Q4 2023 results on February 21, 2024 after market close and host a call for investors the following morning.